TY - JOUR
T1 - Assessment of effect of warfarin adherence on health-related quality of life among warfarin patients using whoqol-bref
AU - Iqbal, Muhammad Shahid
AU - Naqvi, Atta Abbas
AU - Kassab, Yaman Walid
AU - Saad, Eldowaik Mohamed Salah
AU - Iqbal, Muhammad Zahid
AU - Mallhi, Tauqeer Hussain
AU - Al-Saikhan, Fahad I.
AU - Almalki, Ziyad S.
AU - Khan, Salah Ud Din
AU - Haseeb, Abdul
AU - Albassam, Ahmed A.
N1 - Publisher Copyright:
© 2020, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Warfarin therapy adherence is among important measures that often helps in avoiding drug-related problems among warfarin patients. To date, warfarin therapy adherence effect on overall Health-Related Quality of Life (HRQoL) among warfarin patients has not been studied in Malaysia. The aim of our study was to evaluate the association of warfarin therapy adherence with HRQoL among warfarin pa-tients using the WHOQOL-BREF. A prospective and descriptive study was performed among 319 war-farin patients. The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 22.0. The majority of the patients were females than males (n=221, 69.3%, and n=98, 30.7% respective-ly). The mean adherence score for the study population was 6.02 ± 1.27. The mean HRQoL scores for the physical health, psychological, social relationships, and environment domains were 61.14 ± 15.96, 68.58 ± 16.11, 63.55 ± 27.06, and 62.78 ± 17.58 respectively. The correlation coefficients for all four domains of the WHOQOL-BREF vs mean adherence score were-0.015, 0.004,-0.061, and-0.002 respectively. In study findings, statistically non-significant (p > 0.05) correlations were observed between four domains of the WHOQOL-BREF vs total mean adherence score. In the physical, psychological, social and environment domains the r values were-0.015, 0.004,-0.061 and-0.002, respectively.
AB - Warfarin therapy adherence is among important measures that often helps in avoiding drug-related problems among warfarin patients. To date, warfarin therapy adherence effect on overall Health-Related Quality of Life (HRQoL) among warfarin patients has not been studied in Malaysia. The aim of our study was to evaluate the association of warfarin therapy adherence with HRQoL among warfarin pa-tients using the WHOQOL-BREF. A prospective and descriptive study was performed among 319 war-farin patients. The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 22.0. The majority of the patients were females than males (n=221, 69.3%, and n=98, 30.7% respective-ly). The mean adherence score for the study population was 6.02 ± 1.27. The mean HRQoL scores for the physical health, psychological, social relationships, and environment domains were 61.14 ± 15.96, 68.58 ± 16.11, 63.55 ± 27.06, and 62.78 ± 17.58 respectively. The correlation coefficients for all four domains of the WHOQOL-BREF vs mean adherence score were-0.015, 0.004,-0.061, and-0.002 respectively. In study findings, statistically non-significant (p > 0.05) correlations were observed between four domains of the WHOQOL-BREF vs total mean adherence score. In the physical, psychological, social and environment domains the r values were-0.015, 0.004,-0.061 and-0.002, respectively.
KW - HRQoL
KW - Malaysiam warfarin
KW - Warfarin therapy adherence
KW - WHOQOL-BREF
UR - http://www.scopus.com/inward/record.url?scp=85096088648&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85096088648
SN - 0326-2383
VL - 39
SP - 2285
EP - 2292
JO - Latin American Journal of Pharmacy
JF - Latin American Journal of Pharmacy
IS - 11
ER -